Back to today’s briefing

Story perspectives

Sandoz warns Trump’s generic tariffs will raise U.S. costs

9/9/2026

25 6 Full Breakdown

Summary

Story summary

Sandoz CEO Richard Saynor warned that U.S. patients will bear costs of Trump-proposed generic tariffs.
President Donald Trump announced 100% tariffs on imported generics in 2028, rising to 200% in 2029.
Saynor said firms would raise prices or stop supplying drugs if tariffs cause material loss.
Sandoz will add $300 million to a new Ljubljana biosimilar plant after a $1.1 billion Slovenia investment.

1 of 1

Story summary

Sandoz CEO Richard Saynor warned that U.S. patients will bear costs of Trump-proposed generic tariffs.
President Donald Trump announced 100% tariffs on imported generics in 2028, rising to 200% in 2029.
Saynor said firms would raise prices or stop supplying drugs if tariffs cause material loss.
Sandoz will add $300 million to a new Ljubljana biosimilar plant after a $1.1 billion Slovenia investment.